Updates of the Belgian List of reimbursable devices in June 2025

In June 2025, the Belgian National Institute for Health and Disability Insurance (INAMI/RIZIV) updated the List of implants and invasive medical devices. Four new material codes concerning heart valve replacement were added, along with reimbursement fees and related conditions. 

• The example of newly added code is 185776-185780 “Percutaneously implantable valve stent in the aortic position, including the placement system, for patients with an EuroSCORE II ≤8% and ≥4%”.

Furthermore, Nominative lists were updated in June 2025. These lists specify certain brands in connection with material codes on the List of implants and invasive medical devices, when brand-specific registration is required. 

• A total of 12 Nominative lists were updated with multiple new devices added in relation to neuromodulation (deep brain stimulation systems), neurovascular (embolization devices), orthopaedic (including devices for knee and hip replacement), and cardiovascular (transcatheter aortic valve implantation devices, bioprosthetic mitral valves) procedures.

See full details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.